Besides, an earlier study reported that brusatol treatment diminished the production of mitochondrial ROS, leading to the activation of PHDs and subsequent degradation of HIF-1α in colorectal cancer cells [61]. This evidence concerns the gene HIF1A and colorectal cancer.